When Bartonella infections persist, present atypically, or defy standard testing, understanding why they are missed is critical. This webinar examines Bartonella’s stealth biology, non-traditional transmission routes, and diagnostic blind spots through clinically grounded case studies, providing actionable insight for providers navigating complex vector-borne disease presentations.
Standard testing leaves too many tick-borne infections undetected. This clinical webinar explores advanced detection methods to help clinicians find what’s missed when symptoms persist or contradict test results.
Vector-borne pathogens don’t survive by chance, they survive by design. Through immune suppression, antigenic variation, and tissue sequestration, these organisms persist in the host while evading immune clearance and complicating diagnosis.
Borrelia Diagnostics Update (2022) Galaxy Diagnostics cofounder/CEO, Dr. Amanda Elam, and Director of Research and Development/Asst. Lab Director, Dr. Jennifer Miller discuss the latest updates to Borrelia testing and recommendations in this webinar.
Understanding Bartonella: A One Health Perspective (2015)
Approximately 75% of emerging infectious diseases affecting humans are zoonotic (transmitted from animals to humans). Vectors (e.g., fleas, ticks, lice, biting flies, etc.) play an important role in transmitting zoonotic infections. Individuals at high-risk of acquiring Bartonella infection include those who work or live with animals, or those with high exposure to fleas, ticks, lice and biting flies. Stealth infections such as bartonellosis are increasingly implicated in complex chronic disease syndromes, yet are extremely difficult to diagnose accurately.
Bartonella Diagnostics Update (2021) Galaxy cofounders, Dr. Ed Breitschwerdt and Dr. Amanda Elam, discuss the latest updates to Bartonella testing and recommendations in this 45-minute presentation.
